GABAergic neuron-to-glioma synapses in diffuse midline gliomas - NatureDMG is a fatal childhood CNS cancer with a median survival of 11-13 months, often linked to the H3K27M mutation.
Big step toward targeted molecular therapies for cancer - Harvard GazetteNew therapies for cancer may disrupt disease growth through innovative molecular glues and insights into genetic mutations.
Youngest person treated by Nanoknife is cancer-freeGeorge, the youngest patient to receive Nanoknife treatment, is now cancer-free after a groundbreaking procedure that improved surgical margins.
'The best day ever': 2-year-old South Bay girl celebrates end of cancer treatmentLucy Nguyen, a two-year-old girl, celebrated the end of her leukemia treatment by ringing a bell, marking her journey to recovery and resilience.
Youngest person treated by Nanoknife is cancer-freeGeorge, the youngest patient to receive Nanoknife treatment, is now cancer-free after a groundbreaking procedure that improved surgical margins.
'The best day ever': 2-year-old South Bay girl celebrates end of cancer treatmentLucy Nguyen, a two-year-old girl, celebrated the end of her leukemia treatment by ringing a bell, marking her journey to recovery and resilience.
This kids' brain cancer is incurable - but immune therapy holds promiseCAR-T therapy shows promise in treating deadly brain tumors in children.